Clinical trial
A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for…
NCT00333281 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00333281 |
|---|---|
| Title | A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six Months |
| Official title | A Randomized, Double-Blind, Parallel-Design, Placebo-Controlled Study to Evaluate the Effects of 5 mg Tadalafil (IC351, LY450190) and 50 mg Sildenafil Administered Once Daily for 6 Months on Visual Function in Healthy Subjects or Subjects With Mild Erectile Dysfunction |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | ICOS Corporation Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Erectile Dysfunction |
| Intervention type | Drug |
| Interventions | tadalafil |
| Enrollment | 198 |
| Start date | Jun 1, 2005 |
| Completion | Aug 1, 2006 |
| First posted | Jun 2, 2006 |
| Last update posted | Oct 25, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: